chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ten minutes after injection patient started feeling faint/despondenet; Ten minutes after injection patient started feeling faint/despondenet; Cold to the touch, lips were blue; Cold to the touch, lips were blue; Sweating profusely; This spontaneous case was reported by a pharmacist and describes the occurrence of DIZZINESS (Ten minutes after injection patient started feeling faint/despondenet), FEELING OF DESPAIR (Ten minutes after injection patient started feeling faint/despondenet), PARAESTHESIA (Cold to the touch, lips were blue), CYANOSIS (Cold to the touch, lips were blue) and HYPERHIDROSIS (Sweating profusely) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Ten minutes after injection patient started feeling faint/despondenet), FEELING OF DESPAIR (Ten minutes after injection patient started feeling faint/despondenet), PARAESTHESIA (Cold to the touch, lips were blue), CYANOSIS (Cold to the touch, lips were blue) and HYPERHIDROSIS (Sweating profusely). At the time of the report, DIZZINESS (Ten minutes after injection patient started feeling faint/despondenet), FEELING OF DESPAIR (Ten minutes after injection patient started feeling faint/despondenet), PARAESTHESIA (Cold to the touch, lips were blue), CYANOSIS (Cold to the touch, lips were blue) and HYPERHIDROSIS (Sweating profusely) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.
She got her 3rd vaccine, and on Saturday morning at 4:00 AM she woke up with a very bad migraine on the left side, which she does not usually get them that early in the morning.  Also it was on the left side, which she always get them on the right.  She then turned over and had pain in the left arm.  She also had pain in left chest, left leg, ankle, foot and her entire arm. Her hand on her left side and her foot was freezing cold.  She had pain from the wrist to the shoulder, chest, down her hip, down her leg to her foot, but numb and cold on the hand and foot.  She took her migraine medicine and with an hour it worked.  She was fatigued and stayed in the bed a lot longer than usual and is an early riser.  She was fatigued the entire day, and took the whole day to do what usually takes her 30 minutes.  She had no appetite and was tired and the pain.  She went to bed early that evening around 7-8, but when she woke up on Sunday she felt her usual self, and is OK this morning, just tender where she got the vaccine.
The consumer also reported the side effects as being "uncomfortable"; The consumer reported being itchy, on the arm, as well as experiencing swelling and redness; The consumer reported being itchy, on the arm, as well as experiencing swelling and redness; The consumer reported being itchy, on the arm, as well as experiencing swelling and redness; The consumer reported receiving the second dose, of the PNEUMOV AX 23 vaccine, in 2014, and the first dose in 2011.; This spontaneous report was received from a currently 64 years old female patient, referring to herself. The patient's concurrent condition included multiple sclerosis. The patient's concomitant therapy included bupropion hydrochloride (WELLBUTRIN). The patient was allergic to ampicillin, cephalexin (KEFLEX) and sulfacetamide sodium (+) sulfadiazine (+) sulfamethazine (SULFA).  On an unknown date in 2011, the patient was received the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, lot# and expiration date were not reported; route was reported as injection) as a prophylactic. On an unknown date in 2014, the patient was received the second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, lot# and expiration date were not reported; route was reported as injection) as a prophylactic (inappropriate schedule of product administration).  On unknown dates in 2014 (reported as after the 2nd dose), the patient experienced side effects: being itchy, on the arm, as well as experiencing swelling and redness, which had been confirmed by the patient that occurred on the upper arm at the injection site. It was reported that the side effects as being "uncomfortable". No special treatment was given for the events. The outcome of the events was reported as recovered on unknown dates in 2014. The causality assessment between above mentioned events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.
severe tinnitus, persisted continuously for ~ 3days, and has continued intermittently since.
Immediate crying after vaccines at 2 month age. Same day fever to 102 degrees. Fevers times 3 days. Cried non stop for 4 hours day 1. Refused to eat times 8 hrs. For 10 days after vaccines, had irritability and fussing and not sleeping well. Pt not re-evaluated during this time.
Patient woke up on the morning on July 8 and could no longer walk.  He was unable to walk for exactly 28 days.  On August 4th he began walking again.
pt devel mildly pruritic, vesicular, well demarcated erythematous lesions which were 1x1 cm (or less); total of 7 formed 2 were w/in 3-6 inches of inject site others more widespread; began w/in 4 hrs p/inject;
Within couple of day after the vaccination my muscles and bones began to ache.  It progressively got worse to the point I could hardly get out of bed in the morning. I went to the doctor and she put on a five day dose of Prednisone. that did relieve most of the pain. After that she put me on Diclofenac but that did not help much. Around March she put me on 15 MG of prednisone and I have been on that through current date. it helps but having some side effect from the prednisone. My lab work on 4/1/21 showed a CRP-V of 1.9 and my MONO was 14%
like large pimple flat on the skin; (On injection site): red, reddish-pink circle with white dot in the middle, flat on the skin, not inflamed, size like a large pimple or mole; Sweating a lot; Muscle kind of swollen; Body aches; Chills; Headaches; Soreness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SWELLING (Muscle kind of swollen), HYPERHIDROSIS (Sweating a lot), VACCINATION SITE INDURATION (like large pimple flat on the skin), MYALGIA (Body aches) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ARIPIPRAZOLE, BISACODYL (DULCOLAXO), CLOZAPINE (CLOZARIL), DOCUSATE SODIUM, ACETAMINOPHEN, LACTASE, LOPERAMIDE HYDROCHLORIDE (IMODIUM), MULTIVITAMINS [VITAMINS NOS], OXYBUTYNIN, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) and VENLAFAXINE for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced MUSCLE SWELLING (Muscle kind of swollen), MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headaches) and INJECTION SITE PAIN (Soreness on injection site). On 22-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating a lot). On 23-Apr-2021, the patient experienced VACCINATION SITE INDURATION (like large pimple flat on the skin) and INJECTION SITE ERYTHEMA ((On injection site): red, reddish-pink circle with white dot in the middle, flat on the skin, not inflamed, size like a large pimple or mole). On 22-Apr-2021, MUSCLE SWELLING (Muscle kind of swollen), HYPERHIDROSIS (Sweating a lot), MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headaches) and INJECTION SITE PAIN (Soreness on injection site) had resolved. At the time of the report, VACCINATION SITE INDURATION (like large pimple flat on the skin) and INJECTION SITE ERYTHEMA ((On injection site): red, reddish-pink circle with white dot in the middle, flat on the skin, not inflamed, size like a large pimple or mole) had not resolved.            No treatment information was provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: New event added & event coding updated per MA.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a consumer concerning her father-in-law who on 18-MAY-2009 was vaccinated with PNEUMOVAX. It was reported that the patient developed sore arm that was very painful and her had chills all evening long. Additional information has been requested.
Information has been received from a physician concerning a 16 year old female who was vaccinated with two doses of Gardasil. After the patient received the first dose of Gardasil she developed severe itching and swelling of the labia. After the second dose of Gardasil the second incident was more severe than the first incident. After the second dose the patient missed eight days of school and had difficulty walking. She was placed on steroids for eight days and the symptoms resolved. It was reported that the patient did not have a yeast infection. Unknown medical attention was sought in the office. Patient outcome was recovered. No product quality complaint was involved. Additional information has been requested.
posterior occipital lobe stroke causing homonymous hemianopia, thalamic stroke causing memory loss, and inability to recognize or remember known objects. As of now, doctors are calling it idiopathic because they have found no cause after multiple MRIs, CTs, echocardiograms, EEGs, and heart monitoring.
Information has been received from a nurse practitioner concerning a 20 year old male operating room technician who on 02/09/2004 was vaccinated in the left deltoid with a second dose of Hepatitis B virus vaccine rHBsAG (yeast) (646340/1015N).  It was reported that the patient experienced prolonged pain at injection site of three to four days.  Then five days after the injection he experienced a "pinching" sensation at the site of injection, which occurred for one day then resolved.  The patient stated his arm felt normal on 02/19/2004.  There was no product quality complaint reported.  No additional information was received.  Specified medical attention was sought.  No additional information is expected.
hot; "a weird rash" that looks like hives; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot) and URTICARIA ("a weird rash" that looks like hives) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced FEELING HOT (hot) and URTICARIA ("a weird rash" that looks like hives). At the time of the report, FEELING HOT (hot) had resolved and URTICARIA ("a weird rash" that looks like hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included Claritin, Steroid cream and Benadryl. Concomitant medications also included birth control pill .
Pt. developed Peripheral T-cell Lymphoma Oct. 2011. 2nd HPV given Jan. 2009 (most recent immunization). Father feels they are related. Told him I know of no connection.
This spontaneous report as received from a registered nurse refers to a patient of unknown age. On 16-JAN-2014 the patient was vaccinated with a dose of PROQUAD (Merck) (lot # H015789, Exp date: 24-FEB-2014), 0.5 ml, subcutaneously. Other suspect therapy included VARIVAX (Merck) (lot # reported as H016717), 0.5 ml, subcutaneously. No adverse effects reported. Additional information has been requested.
the patient was administered improperly stored PROQUAD; This spontaneous report was received from a medical assistant referring to a 4-year-old female patient. Information regarding the patient's pertinent medical history and drug reactions/allergies was not provided.  On 20-AUG-2020, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose schedule and anatomical location were not reported; lot # T005406 with expiration date 12-AUG-2021) subcutaneously for "well check" (prophylaxis) (product storage error). This vaccine was reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT).  The administered dose of the vaccine experienced multiple temperature excursions which went from -14 degrees Celsius (C) to -10 C for 116 hours; and from -9 C to 8 C (-6.1 C) for 13 hours, as recorded by a data logger. There was no previous temperature excursion.  This is one of multiple reports sent by the same reporter.; Sender's Comments:  US-009507513-2009USA005503: US-009507513-2009USA005097: US-009507513-2009USA005124: US-009507513-2009USA005141: US-009507513-2009USA005142: US-009507513-2009USA005258: US-009507513-2009USA005382: US-009507513-2009USA005515: US-009507513-2009USA005526:
Employee is scheduled for international travel. (India) first dose of Japenc was administered as directed on July 27, 2006.  He noticed a rash on his lower legs with vesicles present, 3 days post, as well as a reddened rash on his forearms.  He did not report the reaction for 10 days.  At that time 3 pinpoint residual scarring noted on his legs.  He never experienced any other symptoms.  Update-employee has now reported going to his physician when he noticed a ruptured vesicle he hadn't noticed before, now on antibiotic.
Vasovagal syncope response during vaccination process. Laid client down, monitored for 20 minutes. Client stated feeling better and no further dizziness. Alert and oriented
Contracted COVID-19. Symptom onset 5/29/2022. First positive test 5/31/2022 (at home test). Started Paxlovid 6/1/2022. Symptoms subsided but rebounded 6/8/2022 for new 10-day isolation. First negative home test 6/16/2022.
I can contact with virus vaccination; contact with the virus after two of the COVID shot; I had Covid; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (,Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as SINGLE DOSE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported and concomitant medications were not reported. The patient was in contact with virus vaccination; contact with the virus after two of the covid shot (drug ineffective) and had covid. Further stated that, tatient had both shot and the first one obviously will give an incredible amount of coverage and had Covid. It was stated that, LOT#: 3321 and 32421, that's all I have. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The outcome for the events was unknown.
having a cellulitis in my arm; my arm is reading is formed it's painful; my arm is reading is formed it's painful; it's reddened; it's warm; Off label use; Booster; This is a spontaneous report from a non contactable other hcp (patient). A 62-years-old female patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number, Expiry date was not reported), dose 3 via an unspecified route of administration on 01Oct2021 (age at vaccination 62-years-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number, Expiry date was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number, Expiry date was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. On 01Oct2021, the patient received my covid booster on friday december first (name) and october first ten one and friday december first (name) received my booster from my employer and ten one twenty-one she think having a syllabus and my arm was reading was formed it was painful and she thought she was having a cellulitis in her arm, it's reddened, it's warm, it's painful and had pain in her zoloft, off label use and booster. The clinical outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the event cellulitis and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.  The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
25 days post vax, the pt was hospitalized with CBC critical values. Dx with pancytopenia.  Follow up 10/13/2000: "This event is due to the cumulative effects of a series of 3 Hep B vaccines.  1st vaccine: No noticeable adverse effects.  2nd vaccine: 1 week later, diagnosis pityriasis rosea rash.  3rd vaccine: 25 days later-hospitalized CBC critical values"
Approximately 6.5hrs after vaccination, patient developed severe fatigue, some palpitations and dizziness.  The next the morning, she had headache, nausea and strange feeling on the tip of throat and nose.  She also had pain and swelling in the injection side, no erythema.
Around 24 hours after my second dose vaccine, I developed cramping and diarrhea which lasted one hour and a half. I then experienced chills and felt very cold and by the afternoon I was running a temperature. By the next morning my symptoms had resolved.
Soreness and redness occurred on right thigh day following immunizations. Leg was warm to touch, urticaria broke out the next day legs bilaterally and torso. Symptoms controlled with Benadryl. Symptoms reoccur daily in the afternoon for several days.
Mild dizziness and slightly nauseous. No other complaints. Drank some water and was observed for 30 minutes. Was "completely fine" when he left. Has follow up with Care Team RN in the morning.
12 hours after shot I developed a headache that quickly progressed into a migraine.  Usually going to bed helps but the pain was so bad on the right side of my head I could not sleep.  5 hours after onset of migraine I began vomiting frequently  for about 6 hours. Headache  and nausea lasted . Was able to sleep on and of.  Still feel nausea and weak with slight headache, 24 hours after onset
On the 19th I was having chest pain and tightness. My watch showed I was having irregular AFIB. And the next morning it happen again, and I went to the hospital. The hospital said I was having a heart attack. And to go to my cardiologist. After that I saw my doctor on Wednesday and got lab work for my thyroid, and checked my potassium, it was low. I am scheduled for an eco-cardiogram and a heart monitor in the next week or so. This AFIB attacks are happened on Sunday Monday and Tuesday, not know I was put on a potassium supplement.
Pain began in left arm immediately after vaccine along with lightheadedness. Arm pain increased over the next few days to include shoulder pain upon movement. Range of motion lessened over the next several days. Made several visits to the chiropractor for stim therapy, laser therapy etc. Pain became increasingly severe leading to a dr appointment on May 14, 2021. X-rays were taken, script for steroids written and a script for PT. Performed PT 2-3 times per week from June-September with little to no decrease in pain. Was sent for an MRI. September 7, 2021. MRI noted mild burial sided fraying of suprasspinatus,diffuse tendinopathy. Anterior and Inferior labral irregularity concerning for tear. Trace fluid in the subacromial/subdeltoid bursa.  Saw surgeon October 12 received Steroid shot. Has not helped much. Continuing in PT.
Chest pain within 5 minutes and heart palpitations every 5 minutes for 30 minutes. After 30 minutes they were their worst and blood pressure was checked to be 140/90.  Heart palpitations and chest pain have not subsided for patient.
Anaphylactic reaction -difficult to breath- cough, skin redness all over body and itchy all over- EPINEPHrine (ADRENALIN) 1 mg/mL injection 0.15 mg Patient transferred to emergency department
Itchy spots chest and back, like mosquito bite; Slight blister; 1st dose 8 months ago, 2nd not yet; This non-serious case was reported by a consumer via call center representative and described the occurrence of pruritus in a 82-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   In SEP-2022, the patient received the 1st dose of Shingrix. On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced pruritus (Verbatim: Itchy spots chest and back, like mosquito bite), blister (Verbatim: Slight blister) and incomplete course of vaccination (Verbatim: 1st dose 8 months ago, 2nd not yet). The outcome of the pruritus and blister were not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the pruritus and blister to be related to Shingrix.     It was unknown if the company considered the pruritus and blister to be related to Shingrix.   Additional Information: GSK Receipt Date: 03-MAY-2023 The reporter was the patient. The patient received his first dose of Shingrix about 8 months ago and had not yet received the second dose (AE-Inappropriate schedule of vaccine). For the last 2-3 months, the patient had been experiencing itchy spots on his chest and back which were reminiscent of a past outbreak of shingles.  The patient described the itchy spots as mosquito bite like with a slight blister. The reporter consented to follow up. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Patient reported on 2/9 that she started having shortness of breath, rapid HR, itchy skin, hand and feet redness.  Her endo specialist advised her to take Claritin gel caps for 3 days.  The reaction lasted 2 days and was advised not to take the 2nd shot.
CUSTOMER STATES THAT THE ARM FEELS NUMB OR "ASLEEP". THIS HAPPENED A FEW WEEKS AGO BUT DID NOT KNOW HOW THE SHOT AFFECTED HER ARM.